Which of the following adverse effects of phenytoin require monitoring and are considered hallmark effects?

• A. Nystagmus, ataxia, diplopia; gingival hyperplasia; hirsutism; rash including risk of Stevens-Johnson in rare cases; teratogenic effects.
• B. Weight gain and liver enzyme elevation only.
• C. Hypotension and bradycardia.
• D. Photosensitivity and hair loss.

Answer: (A)

Phenytoin has a narrow therapeutic index, so effects that signal toxicity or require ongoing surveillance are the ones clinicians watch closely. Early CNS signs—nystagmus, ataxia, and diplopia—reflect rising central nervous system exposure to the drug and often prompt a check of serum levels or a dose adjustment. These are classic indicators that the drug effect is becoming too strong.

Gingival hyperplasia is a well-recognized long-term adverse effect tied to phenytoin use. It develops with continued therapy and dental hygiene monitoring helps manage it, sometimes even requiring dental intervention. Hirsutism is another common, dose-related side effect that patients often notice and discuss with their clinician, reinforcing the need for monitoring and counseling about cosmetic changes.

A serious but rarer reaction is a rash, including the possibility of Stevens-Johnson syndrome. Its potential for severe dermatologic consequences means it must be actively watched for, especially early in therapy or after dose changes. Teratogenic effects are crucial to monitor in women of childbearing potential, since phenytoin exposure can cause fetal anomalies; this prompts counseling, pregnancy planning considerations, and risk-benefit discussions.

Together, these effects highlight why phenytoin requires regular monitoring—through clinical observation for toxicity signs, periodic wellness checks (including dental and dermatologic surveillance), and laboratory or counseling steps when pregnancy or drug interactions are involved.